KIR2DS4 and glioblastoma: In our study, we cannot completely rule out that KIR2DS4 influenced subtle tuning of NKG2C+ NK cell cytotoxicity towards HT18584 and HT18816 GBM target cells with expression of the cognate HLA ligands.